Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Chair
Member
| Audit Committee | Position |
|---|---|
|
Audit Committee Charter |
Download |
| Compensation Committee | Position |
|---|---|
|
Compensation Committee Charter |
Download |
| Nominating and Corporate Governance Committee | Position |
|---|---|
|
Nominating and Corporate Governance Committee Charter |
Download |